• Profile
Close

A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients

Drug Design, Development and Therapy Aug 30, 2017

Nosek K, et al. – This study was designed to compare analgesia and adverse effects of oral morphine and oxycodone and transdermal fentanyl and buprenorphine administration in cancer patients with pain. Investigations suggested that all opioids were effective and well–tolerated. Morphine was the most effective in the improvement in some of the Brief Pain Inventory–Short Form items regarding the negative impact of pain on patients’ daily activities. Moreover, the prophylaxis of constipation was effective.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay